Withdrawn application: Brilique, 15/12/2021

Human medicines European public assessment report (EPAR): Rubraca, rucaparib, Date of authorisation: 23/05/2018, Revision: 18, Status: Authorised

Call for expressions of interest for civil society representatives to participate in the work of EMA’s Paediatric Committee

Human medicines European public assessment report (EPAR): Celdoxome pegylated liposomal, doxorubicin hydrochloride, Date of authorisation: 15/09/2022, Revision: 3, Status: Lapsed

PSUSA/00000843/202501

Medicines authorised during pandemic

Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 38, Status: Authorised

Paediatric investigation plans: Templates and forms

Clinical Trials Information System (CTIS): Walk-in clinic November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 19 November 2025, 16:00 (CET) to 19 November 2025, 17:00 (CET)

Human medicines European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), dinutuximab beta, Date of authorisation: 08/05/2017, Revision: 18, Status: Authorised